2.0
Jul 25, 2013
Recommend
CEO approval
Business Outlook
Pros
Hard to say. The virtual DR product was/is(?) intriguing.
Cons
With ebitda managed in each Market, the market aim/offering is quite low. There is a managed offering but I can't see why anyone who shops around would want it. The acquisition by Welsh-Carson has brought the normal ebb and flow of corporate oversight which probably explains why they're not expanding to new markets all that much. With the low margins in colo, its hard to imagine a rosey future for these guys... The "e-team" other than Jones is suspect. There are guys in VP roles who were and probably still are a bit clueless. Big egos, and a lot of bluster on the team.
